Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 2529 entries
View as:

Study of BGG492 in Patients With Chronic Subjective Tinnitus

Phase: N/A Priority: Normal
NCT ID: NCT01302873 Org: User:
Start: 01/31/11 End: 01/31/12 Due: 01/31/13

Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00454051 Org: User:
Start: 12/31/06 End: 03/31/08 Due: 03/31/09

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Phase: N/A Priority: Normal
NCT ID: NCT05948943 Org: User:
Start: 11/24/23 End: 05/02/33 Due: 05/02/34

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT01044186 Org: User:
Start: 06/30/03 End: - Due: -

Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00372697 Org: User:
Start: 12/31/05 End: 10/31/07 Due: 10/31/08

A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica

Phase: N/A Priority: Normal
NCT ID: NCT01364389 Org: User:
Start: 02/14/11 End: 01/29/13 Due: 01/29/14

SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

Phase: N/A Priority: Normal
NCT ID: NCT00371826 Org: User:
Start: 03/31/06 End: 06/30/12 Due: 06/30/13

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT05977322 Org: User:
Start: 10/06/23 End: 12/13/24 Due: 12/13/25

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany

Phase: N/A Priority: Normal
NCT ID: NCT05305664 Org: User:
Start: 08/19/22 End: 01/28/25 Due: 01/28/26

Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00333840 Org: User:
Start: 06/30/00 End: 03/31/12 Due: 03/31/13

A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03517566 Org: User:
Start: 11/14/18 End: 08/06/20 Due: 08/06/21

Second Open Label Extension to Bridging Study CTBM100C2303

Phase: N/A Priority: Normal
NCT ID: NCT01069705 Org: User:
Start: 02/12/10 End: 03/19/12 Due: 03/19/13

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Phase: N/A Priority: Normal
NCT ID: NCT00446082 Org: User:
Start: 06/30/06 End: 11/30/13 Due: 11/30/14

Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.

Phase: N/A Priority: Normal
NCT ID: NCT06905288 Org: User:
Start: 04/02/25 End: 06/30/26 Due: 06/30/27

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00171847 Org: User:
Start: 03/31/03 End: - Due: -

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT01137682 Org: User:
Start: 07/19/10 End: 02/28/17 Due: 02/28/18

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02034110 Org: User:
Start: 03/12/14 End: 12/10/21 Due: 12/10/22

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam

Phase: N/A Priority: Normal
NCT ID: NCT05386680 Org: User:
Start: 01/12/23 End: 11/29/24 Due: 11/29/25

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Phase: N/A Priority: Normal
NCT ID: NCT00889863 Org: User:
Start: 07/31/09 End: 09/30/11 Due: 09/30/12

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01872260 Org: User:
Start: 10/22/13 End: 12/31/25 Due: 12/31/26

Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00529529 Org: User:
Start: 09/30/07 End: 08/31/08 Due: 08/31/09

Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00098735 Org: User:
Start: 04/30/04 End: - Due: -

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Phase: N/A Priority: Normal
NCT ID: NCT01061177 Org: User:
Start: 05/31/10 End: 07/31/14 Due: 07/31/15

Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.

Phase: N/A Priority: Normal
NCT ID: NCT04623216 Org: User:
Start: 09/14/21 End: 08/22/24 Due: 08/22/25

Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia

Phase: N/A Priority: Normal
NCT ID: NCT04784390 Org: User:
Start: 06/30/21 End: 08/03/22 Due: 08/03/23